Moneycontrol PRO

trends

Rationalising R&D operations: Lupin scaling down drug discovery programme

Pharma major Lupin has started to rationalise its R&D operations. The company has decided to scale down the drug discovery programme to focus on more near-term and mid-term opportunities. CNBC-TV18's Ekta Batra gave us more details.

first published: Sep 12, 2017 08:33 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347